Cancer stem cells, the ultimate targets in cancer therapy

Ahmed Shabbir¹, Tuba Esfandyari², Faris Farassati^{1

3

4}

Affiliations

¹ Midwest Biomedical Research Foundation, Kansas City Veterans Affairs Medical Center.
² Department of Medicine, School of Medicine, The University of Kansas.
³ Saint Luke's Cancer Institute.
⁴ Saint Luke's Marion Bloch Neuroscience Institute, Saint Luke's Health System, Kansas City, MO, USA.

Editorial

Ahmed Shabbir et al. Onco Targets Ther. 2018.

. 2018 Jan 3:11:183-184.

doi: 10.2147/OTT.S154431. eCollection 2018.

Ahmed Shabbir¹, Tuba Esfandyari², Faris Farassati^{1

3

4}

¹ Midwest Biomedical Research Foundation, Kansas City Veterans Affairs Medical Center.
² Department of Medicine, School of Medicine, The University of Kansas.
³ Saint Luke's Cancer Institute.
⁴ Saint Luke's Marion Bloch Neuroscience Institute, Saint Luke's Health System, Kansas City, MO, USA.

No abstract available

Conflict of interest statement

Disclosure The authors report no conflicts of interest in this work.

1. Polyak K, Hahn WC. Roots and stems: stem cells in cancer. Nat Med. 2006;12:296–300. - PubMed
1. Aguirre-Ghiso JA. Models, mechanisms and clinical evidence for cancer dormancy. Nat Rev Cancer. 2007;7:834–846. - PMC - PubMed
1. Fujiki H, Sueoka E, Rawangkan A, Suganuma M. Human cancer stem cells are a target for cancer prevention using (−)-epigallocatechin gallate. J Cancer Res Clin Oncol. 2017 Sep 23; Epub. - PMC - PubMed
1. Aponte PM, Caicedo A. Stemness in cancer: stem cells, cancer stem cells, and their microenvironment. Stem Cells Int. 2017;2017:5619472. - PMC - PubMed
1. Takebe N, Miele L, Harris PJ, et al. Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update. Nat Rev Clin Oncol. 2015;12:445–464. - PMC - PubMed